To further confirm the UBXN2A‐dependent reduction in mot‐2 proteins in cancer cells, we used a Tet‐on system to induce the expression of UBXN2A in HCT‐116 colon cancer cells. The gene discussed is UBXN2A; the disease is colonic neoplasm.